Funding
Series D · Healthtech

Zenflow raises $52m Series D for Spring System commercialisation

A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.

Updated Oct 16, 2026By RoundOS Funding desk

Zenflow raised $52 million in Series D funding, with ClavystBio, F-Prime and Trinity Capital recorded as participants.

Proceeds support commercialisation of the Spring System alongside an exclusive US distribution partnership with Cook Medical. The small office-delivered implant is designed to relieve urinary symptoms associated with an enlarged prostate.

Funding history

Series D · This round$52M

Sources

  1. Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical - BioSpacebiospace.com · Oct 5, 2026
  2. startupdb.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
SEGNOS

SEGNOS develops magnetic-particle materials and diagnostic technologies for blood testing.

UndisclosedPre-Series A · Oct 22, 2026
CureBay

CureBay operates a hybrid healthcare network for rural and underserved communities in India.

~₹1BPre-Series C · Oct 22, 2026
iCUREX

Kagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.

¥140MSeries A first close: equity and debt · Oct 22, 2026

Related